In noninvasive prenatal testing (NIPT), a maternal blood sample provides maternal DNA as well as DNA from the pregnancy to screen prenatal chromosomal abnormalities using next-generation sequencing, or NGS. Dr. Ronald J. Wapner, Vice Chair of Research in Obstetrics and Gynecology for Columbia University, joins me to share his perspective on prenatal screening and NIPT.